These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21653771)

  • 21. TB or not TB? Definitive determination of species within the Mycobacterium tuberculosis complex in unprocessed sputum from adults with presumed multidrug-resistant tuberculosis.
    Mbelele PM; Sauli E; Mpolya EA; Mohamed SY; Addo KK; Mfinanga SG; Heysell SK; Mpagama S
    Trop Med Int Health; 2021 Sep; 26(9):1057-1067. PubMed ID: 34107112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
    Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
    Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment.
    Friedrich SO; Rachow A; Saathoff E; Singh K; Mangu CD; Dawson R; Phillips PP; Venter A; Bateson A; Boehme CC; Heinrich N; Hunt RD; Boeree MJ; Zumla A; McHugh TD; Gillespie SH; Diacon AH; Hoelscher M;
    Lancet Respir Med; 2013 Aug; 1(6):462-70. PubMed ID: 24429244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility.
    Geleta DA; Megerssa YC; Gudeta AN; Akalu GT; Debele MT; Tulu KD
    BMC Microbiol; 2015 Oct; 15():220. PubMed ID: 26483194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study.
    Rachow A; Zumla A; Heinrich N; Rojas-Ponce G; Mtafya B; Reither K; Ntinginya EN; O'Grady J; Huggett J; Dheda K; Boehme C; Perkins M; Saathoff E; Hoelscher M
    PLoS One; 2011; 6(6):e20458. PubMed ID: 21738575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased detection of smear-negative pulmonary tuberculosis by GeneXpert MTB/RIF® assay after bleach concentration.
    Tadesse M; Aragaw D; Rigouts L; Abebe G
    Int J Mycobacteriol; 2016 Jun; 5(2):211-8. PubMed ID: 27242234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective Analysis of False-Positive and Disputed Rifampin Resistance Xpert MTB/RIF Assay Results in Clinical Samples from a Referral Hospital in Hunan, China.
    Hu P; Zhang H; Fleming J; Zhu G; Zhang S; Wang Y; Liu F; Yi S; Chen Z; Chen Z; Liu B; Gong D; Wan L; Wang X; Tan Y; Bai L; Bi L
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30674578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance evaluation of three commercial molecular assays for the detection of Mycobacterium tuberculosis from clinical specimens in a high TB-HIV-burden setting.
    Matabane MM; Ismail F; Strydom KA; Onwuegbuna O; Omar SV; Ismail N
    BMC Infect Dis; 2015 Nov; 15():508. PubMed ID: 26553046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the FluoroType
    Haasis C; Rupp J; Andres S; Schlüter B; Kernbach M; Hillemann D; Kranzer K
    Tuberculosis (Edinb); 2018 Dec; 113():76-80. PubMed ID: 30514516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic performance of the GenoType MTBDRplus version 2 line probe assay is equivalent to that of the Xpert MTB/RIF assay.
    Barnard M; Gey van Pittius NC; van Helden PD; Bosman M; Coetzee G; Warren RM
    J Clin Microbiol; 2012 Nov; 50(11):3712-6. PubMed ID: 22972826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of Second-Generation Line Probe Assay (Hain MTBDR
    Rockwood N; Wojno J; Ghebrekristos Y; Nicol MP; Meintjes G; Wilkinson RJ
    J Clin Microbiol; 2017 May; 55(5):1508-1515. PubMed ID: 28249999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation.
    Dharan NJ; Amisano D; Mboowa G; Ssengooba W; Blakemore R; Kubiak RW; Armstrong DT; Jones M; Manabe YC; Joloba ML; Ellner JJ; Dorman SE; Alland D
    J Clin Microbiol; 2015 Apr; 53(4):1258-63. PubMed ID: 25653410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China.
    Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z
    BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discordance in Xpert
    Sahrin M; Rahman A; Uddin MKM; Kabir SN; Kabir S; Houpt E; Banu S
    Int J Tuberc Lung Dis; 2018 Sep; 22(9):1056-1062. PubMed ID: 30092872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW
    PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
    Ciftçi IH; Aslan MH; Aşık G
    Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
    Ozkutuk N; Surucüoglu S
    Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.